ArticleAdvances in radiation oncology2026
Dosimetric Feasibility of Dose-Painting Radiation Therapy for Targeting Hypoxia in Prostate Cancer on a Novel Ring Gantry Radiation Therapy System.
Article in Advances in radiation oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Hypoxia is a well-known major factor contributing to the radioresistance of prostate cancer, which could be counteracted by increasing the dose. This study aimed to demonstrate the dosimetric feasibility of a dose-painting radiation therapy plan for prostate cancer, using a novel ring gantry system, based on the localization of tumoral and hypoxic areas. Methods and Materials: Seven patients from the Programme d'Action Intégré de Recherche-prostate study, who underwent external-beam radiation therapy for intermediate-risk prostate cancer and exhibited pretherapeutic fluromisonodazole positron emission tomography (PET) uptake in the tumor, were selected. The gross tumor volume (GTV) was delineated on the magnetic resonance imaging, and the hypoxic region within the planning target volume was delineated based on fluromisonodazole PET uptake. Intensity modulated radiation therapy planning was performed based on 3 different prescriptions: standard fractionation (77 Gy in 35 fractions to the planning target volume), with an integrated boost of 95 Gy and 118 Gy in 35 fractions to the GTV and the hypoxic region, moderate hypofractionation (60 Gy in 20 fractions) with a boost of 67 Gy and 91 Gy to the GTV and the hypoxic region, and high hypofractionation (40 Gy in 5 fractions) with a boost of 50 Gy to the GTV and as high as possible to the hypoxic region. Planning was performed on the research version of the RefleXion treatment planning system. Results: We achieved the prescribed dose in all 7 patients while respecting the usual dose limits for organs at risk. Conclusions: This study demonstrated the dosimetric feasibility of dose escalation in both the tumor and hypoxic regions in patients with prostate cancer using the RefleXion treatment planning system, without compromising the dose limits for organs at risks.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.